Works matching IS 10837159 AND DT 2023 AND VI 28 AND IP 7


Results: 27
    1
    3
    4
    5
    6
    7
    8

    The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.

    Published in:
    Oncologist, 2023, v. 28, n. 7, p. 628, doi. 10.1093/oncolo/oyad119
    By:
    • Tesileanu, C Mircea S;
    • Michaleas, Sotirios;
    • Ruiz, Rocio Gonzalo;
    • Mariz, Segundo;
    • Fabriek, Babs O;
    • Hennik, Paula B van;
    • Dedorath, Jutta;
    • Dekic, Bruna;
    • Unkrig, Christoph;
    • Brandt, Andreas;
    • Koenig, Janet;
    • Enzmann, Harald;
    • Delgado, Julio;
    • Pignatti, Francesco
    Publication type:
    Article
    9
    10
    11
    12
    13

    Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.

    Published in:
    Oncologist, 2023, v. 28, n. 7, p. 642, doi. 10.1093/oncolo/oyad058
    By:
    • Madan, Ravi A;
    • Bilusic, Marijo;
    • Stein, Mark N;
    • Donahue, Renee N;
    • Arlen, Philip M;
    • Karzai, Fatima;
    • Plimack, Elizabeth;
    • Wong, Yu-Ning;
    • Geynisman, Daniel M;
    • Zibelman, Matthew;
    • Mayer, Tina;
    • Strauss, Julius;
    • Chen, Gang;
    • Rauckhorst, Myrna;
    • McMahon, Sheri;
    • Couvillon, Anna;
    • Steinberg, Seth;
    • Figg, William D;
    • Dahut, William L;
    • Schlom, Jeffrey
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

    Published in:
    Oncologist, 2023, v. 28, n. 7, p. e526, doi. 10.1093/oncolo/oyad090
    By:
    • Fukushima, Taito;
    • Morimoto, Manabu;
    • Kobayashi, Satoshi;
    • Ueno, Makoto;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Kusano, Chika;
    • Chuma, Makoto;
    • Numata, Kazushi;
    • Tsuruya, Kota;
    • Arase, Yoshitaka;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Ikeda, Hiroki;
    • Watanabe, Tsunamasa;
    • Tanaka, Katsuaki;
    • Maeda, Shin
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.

    Published in:
    Oncologist, 2023, v. 28, n. 7, p. e565, doi. 10.1093/oncolo/oyac145
    By:
    • Terazawa, Tetsuji;
    • Kato, Takeshi;
    • Goto, Masahiro;
    • Ohta, Katsuya;
    • Satake, Hironaga;
    • Noura, Shingo;
    • Kagawa, Yoshinori;
    • Kawakami, Hisato;
    • Hasegawa, Hiroko;
    • Yanagihara, Kazuhiro;
    • Shingai, Tatsushi;
    • Nakata, Ken;
    • Kotaka, Masahito;
    • Hiraki, Masayuki;
    • Konishi, Ken;
    • Nakae, Shiro;
    • Sakai, Daisuke;
    • Kurokawa, Yukinori;
    • Shimokawa, Toshio;
    • Tsujinaka, Toshimasa
    Publication type:
    Article